Literature DB >> 15529408

Effects of benzo(a)pyrene on protein expression in Jurkat T-cells.

Sangnam Oh1, Hosub Im, Eunha Oh, Joohyun Lee, Jin-Young Khim, Joohee Mun, Yanghee Kim, Eunil Lee, Joon Kim, Donggeun Sul.   

Abstract

Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental pollutants of air, water and soil, and are produced by the incomplete combustion of organic materials. The International Agency for Research on Cancer has characterized PAHs as carcinogens. In this study, we investigated the effects of benzo(a)pyrene (B(a)P), which is the most carcinogenic member of the PAHs, on Jurkat cell protein by proteomic analysis. Jurkat cells were treated with various concentrations of B(a)P (0, 2.5, 5, 10, 20 or 40 microM) for 24 or 48 h and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and lactate dehydrogenase assays were carried out to determine cytotoxicity and a Comet assay was used to determinate genotoxicity. The cytotoxicity assays showed that 2.5 microM of B(a)P was the maximal concentration that did not cause any toxicity, but nevertheless, at this level B(a)P produced significant DNA damage in Jurkat cells at 48 h. Proteomic analysis using three different pI ranges and large two-dimensional gel electrophoresis showed 3427 protein spots. A total of 46 (13 up- and 33 down-regulated) proteins were identified as biomarkers of B(a)P and showed dose-dependent expressions in Jurkat T-cell line exposed to B(a)P. Of these, 27 protein spots were identified by matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Two functionally differentiated protein groups were found. The protein group involving apoptosis and tumor suppression were found to be up-regulated, and B(a)P down-regulated enzyme was involved in energy metabolism, DNA synthesis and in cell structure and motility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15529408     DOI: 10.1002/pmic.200400981

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  6 in total

Review 1.  Contributions to our understanding of T cell physiology through unveiling the T cell proteome.

Authors:  M M Grant; D Scheel-Toellner; H R Griffiths
Journal:  Clin Exp Immunol       Date:  2007-05-04       Impact factor: 4.330

2.  Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination.

Authors:  O D Reyes-Hernández; A Mejía-García; E M Sánchez-Ocampo; M A Cabañas-Cortés; P Ramírez; L Chávez-González; F J Gonzalez; G Elizondo
Journal:  Biochem Pharmacol       Date:  2010-05-15       Impact factor: 5.858

3.  Benzo[a]pyrene increases the Nrf2 content by downregulating the Keap1 message.

Authors:  Phuong Minh Nguyen; Miki Susanto Park; Marilynn Chow; Jae H Chang; Lisa Wrischnik; William K Chan
Journal:  Toxicol Sci       Date:  2010-05-23       Impact factor: 4.849

4.  Induction of cell death, DNA strand breaks, and cell cycle arrest in DU145 human prostate carcinoma cell line by benzo[a]pyrene and benzo[a]pyrene-7,8-diol-9,10-epoxide.

Authors:  Onyinye Nwagbara; Selina F Darling-Reed; Alicia Tucker; Cynthia Harris; Michael Abazinge; Ronald D Thomas; Richard D Gragg
Journal:  Int J Environ Res Public Health       Date:  2007-03       Impact factor: 3.390

5.  Proteomics and Network Analyses Reveal Inhibition of Akt-mTOR Signaling in CD4+ T Cells by Mycobacterium tuberculosis Mannose-Capped Lipoarabinomannan.

Authors:  Ahmad F Karim; Obondo J Sande; Sara E Tomechko; Xuedong Ding; Ming Li; Sean Maxwell; Rob M Ewing; Clifford V Harding; Roxana E Rojas; Mark R Chance; W Henry Boom
Journal:  Proteomics       Date:  2017-11       Impact factor: 3.984

6.  Genome-Wide Transcriptional and Functional Analysis of Human T Lymphocytes Treated with Benzo[α]pyrene.

Authors:  Marie Liamin; Hélène Le Mentec; Bertrand Evrard; Laurence Huc; Frédéric Chalmel; Elisa Boutet-Robinet; Eric Le Ferrec; Lydie Sparfel
Journal:  Int J Mol Sci       Date:  2018-11-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.